Neutral
Johnson & Johnson proposes $5.5 billion talc settlement to end lawsuits
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging that its talc-based products caused ovarian cancer. The settlement is contingent upon at least 95% of claimants agreeing to the terms. This move aims to conclude over a decade of legal disputes and allow the company to focus on its core medical and technological initiatives.
Key points
- Johnson & Johnson has agreed to pay $5.5 billion to settle remaining lawsuits alleging its talc products caused ovarian cancer.
- The settlement is contingent upon at least 95% of the remaining claimants participating.
- The company plans to make an initial payment of up to $3 billion in 2027, with no further payments due until 2028.
Sources
AI-generated from public news sources. Not financial advice.
